-
Aug 5, 2015, 12:35 PM
by
Michael Croft
Xconomy | Illumina has announced the second class of its accelerator program, with applications in infectious disease diagnostics, sequencing of urine samples, and even wine making.
Full story
-
Aug 4, 2015, 13:09 PM
by
Michael Croft
SAN FRANCISCO, CA, UNITED STATES - Aug 4, 2015 - Since the classical studies of Jacob and Monod in the early 1960s, it has been evident that genome sequences contain not only blueprints for genes and the proteins that they encode, but also the instructions for a coordinated regulatory program that governs when, where and to what extent these genes and proteins are expressed
Full story
-
Aug 4, 2015, 11:35 AM
by
Michael Croft
FierceBiotech | Shire, the Dublin-headquartered pharma company increasingly reliant on its rare disease portfolio, is making an aggressive move to acquire the newly spun-off biotech company Baxalta.
Full story
-
Aug 3, 2015, 08:30 AM
by
Michael Croft
Nature News | Genome wide association studies, coupled with experiments in the lab, suggest that the small percentage of human DNA contributed by other hominid species like Neanderthals and Denisovans may have large phenotypic effects.
Full story
-
Jul 30, 2015, 15:00 PM
by
Michael Croft
Bio-IT World Brief | Yesterday President Obama has signed an executive order creating the National Strategic Computing Initiative. The Initiative aims to bring together several government agencies including the Department of Energy, Department of Defense, and the National Science Foundation to pursue exascale computing.
Full story
-
Jul 29, 2015, 09:25 AM
by
Michael Croft
Bio-IT World | News and product briefs from around the industry, including Deep Genomins' DNA binding analytics and White House announcements about the Precision Medicine Initiative.
Full story
-
Jul 29, 2015, 00:00 AM
by
Michael Croft
Nature News & Comment | Visionary leader of
China's BGI tells Nature why he is stepping down to build a
health-monitoring system based on a million genomes.
Full story
-
Jul 28, 2015, 00:00 AM
by
Michael Croft
BostonGlobe.com | Cambridge biotechnology giant
Biogen Inc. may have to make a bold move to reassure investors --
buying back shares or snapping up a smaller company -- or it could
become a takeover target itself, some analysts warned Monday.
Full story
-
Jul 28, 2015, 00:00 AM
by
Michael Croft
Computerworld | Going forward, Amazon will
position Aurora as its default database service, a high-performance
alternative to MySQL.
Full story
-
Jul 27, 2015, 11:00 AM
by
Michael Croft
Bio-IT World | Human Longevity's vision is grand: sequence 100,000 human genomes a year and "change the way medicine is practiced by helping to shift to a more preventive, genomic-based medicine model.” Yaron Turpaz, HLI’s Chief Information Officer, talks about the first year’s progress and the kind of knowledgebase HLI is building.
Full story
-
Jul 24, 2015, 08:05 AM
by
Michael Croft
Bio-IT World | Members of MIT's Synthetic Biology Center have successfully reengineered the genome of Bacteroides thetaiotaomicron to take on new functions inside the gut of a mouse in response to changes in the mouse's diet — the first example of implementing these "genetic circuits" in a bacterium that is highly abundant in the human microbiome.
Full story
-
Jul 24, 2015, 00:00 AM
by
Michael Croft
Nature News & Comment | Jun Wang is leaving
his post as chief executive of the Chinese genomics powerhouse BGI,
to pursue research in artificial intelligence.
Full story
-
Jul 23, 2015, 12:00 PM
by
Michael Croft
Bio-IT World | If you missed the lightening round that is Chris Dagdigian’s annual Trends from the Trenches talk at Bio-IT World this year, you’ll have another opportunity to catch up at BioTeam’s first Converged IT Summit in San Francisco this September 9-10. I’m sure Dags will have plenty new to say in his keynote presentation, and he’s not the only one. The Summit agenda features two solid days of leaders who are deploying scientific computing infrastructure for life sciences and healthcare.
Full story
-
Jul 23, 2015, 12:00 PM
by
Michael Croft
Bio-IT World Contributed Commentary | The European Medicines Agency (EMA) has mandated that all life sciences organizations in Europe and those selling products in Europe demonstrate compliance with the Identification of Medicinal Products (IDMP) standards by July 1, 2016. It’s now imperative for IT and business groups to begin formulating a strategy to not just comply with IDMP, but to embrace it as an impetus for change within the organization.
Full story
-
Jul 23, 2015, 00:00 AM
by
Michael Croft
Computerworld | Google on Thursday had its sights
fixed firmly on Amazon as it launched its new, low-cost Nearline
cloud storage service out of beta and into general availability.
Full story
-
Jul 22, 2015, 13:00 PM
by
Michael Croft
Bio-IT World | 23andMe today shut down an app built with its API that purported to enable web developers to “restrict access to your site based on traits including sex, ancestry, disease susceptibility [stet], and arbitrary characteristics associated with single-nucleotide polymorphisms (SNPs) in a person's genotype.”
Full story
-
Jul 22, 2015, 00:00 AM
by
Michael Croft
Washington Post | A painful chapter in his life
motivates a researcher to bring deep learning to genomics.
Full story
-
Jul 21, 2015, 12:15 PM
by
Michael Croft
Bio-IT World News Brief | Oxford Nanopore Technologies announced today that it has raised an additional $109 million in funding for product development and to ramp up manufacturing, coinciding with open applications to join an early access program for the company's first high-throughput instrument.
Full story
-
Jul 21, 2015, 11:00 AM
by
Michael Croft
Bio-IT World | AncestryDNA and Google’s Calico today announced an effort to investigate human heredity of lifespan. The two will analyze and investigate the role of genetics and its influences in families experiencing unusual longevity using Ancestry’s proprietary databases, tools and algorithms. Calico will then focus its efforts to develop and commercialize any potential therapeutics that emerge from the analysis.
Full story
-
Jul 20, 2015, 00:00 AM
by
Michael Croft
NEW YORK, NY - Jul 20, 2015 - Creative Bioarray, an innovative biotechnology company who supplies research-use cells, cell culture medium and reagents, FISH probes, tissue array, microorganisms, equipments and related services, etc, has announced its Whole Chromosome Painting Probes to bio-research community
Full story